SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nancy McKinney who wrote (5238)8/17/1998 12:30:00 PM
From: Ron Sigourney  Read Replies (2) of 7041
 
Nancy,

Nobady has ever said that Vasomax was more effective than Viagra, we know that. Is Viagra more effective than Muse? I'll bet not. But look at the difference in their stock prices today. The key here is in the mode of delivery, and I would definitly prefer a pill to the Muse method.

Vasomax is a fast acting, faster than Viagra, pill. The PIII results show it works. SGP had their scientists evaluate it. SGP put the NDA together, and they were very careful to dot all the i's and cross all the t's. SGP bid for and recieved the world wide marketing rights, and is currently selling the product in Mexico. Zonagen has started receiving royality checks. In addition, Sept 12, 1998, is the deadline for the FDA to accept or reject the NDA. If accepted that is an additional $5MM milestone payment from SGP. No rational reason to believe the NDA will not be accepted.

So why would someone not invest in this stock? Is it a $200 stock, IMHO no. But it is a solid, growing, R&D company with a bright future.

All IMHO.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext